Press releases
2025-08-28 08:17
Lipum AB – interim report Q2 for the period January-June 2025
Lipum AB (publ) has published the interim report Q2 for the period January-June 2025. Below is a summary, a complete report (only in Swedish) is available...
2025-08-07 08:30
Lipum Welcomes Tobias Helgesson as New Chief Financial Officer
Lipum AB (publ) has appointed Tobias Helgesson as its new Chief Financial Officer (CFO). He succeeds Marina Norberg, who will remain with the company during...
2025-08-01 15:00
Lipum AB (publ) has decided to postpone the interim report Q2 2025 to August 28, 2025
The previously announced publication date for the interim report Q2 2025 was August 14. The publication has now been postponed to August 28, 2025. ContactsOla...
Lipum AB (publ) today announces the allocation of warrants in series TO A 2025/2028 and TO B 2025/2028, as resolved at the company’s Annual General...
2025-05-26 08:10
Lipum AB (publ) has published the company’s annual report for the financial year 2024.
The shareholders of Lipum are invited to the Annual General Meeting on June 16, 2025, at 1:00 PM at Lipum’s office, Tvistevägen 48C, 907 36...
2025-04-24 08:00
Lipum AB – interim report Q1 for the period January-March 2025
Lipum AB (publ) has published the interim report Q1 for the period January-March 2025. Below is a summary, a complete report (only in Swedish) is available...
2025-04-11 11:28
Lipum Announces Successful Completion of Phase I Trial for SOL-116 - Supporting Continued Clinical Development
Lipum AB (publ) announces the completion and publication of the Clinical Study Report (CSR) for its First-in-Human (FIH) Phase I trial evaluating SOL-116...
2025-04-07 13:00
Lipum AB (publ) has decided to postpone the Annual General Meeting for the financial year 2024 to June 16, 2025
The previous date for the Annual General Meeting for the financial year 2024 was May 14, 2025, but is now postponed to June 16, 2025. ContactsOla Sandborgh...
2025-02-26 08:30
Lipum AB – Year-end report 2024
Lipum AB (publ) has published the Q4 interim and year-end report for 2024. Below is a summary, a complete report (only in Swedish) is available on the...
2025-02-25 10:07
Lipum has successfully completed the phase I study with SOL-116
Lipum AB (publ) announces the completion of its phase I clinical trial (LPM-116-001) evaluating SOL-116, with positive results. The study confirmed SOL-116’s...